Treatment strategies to resectable metachronous colorectal liver metastases after adjuvant oxaliplatin-based chemotherapy for primary colorectal cancer.
Fiche publication
Date publication
avril 2022
Journal
Journal of surgical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PESSAUX Patrick
Tous les auteurs :
Julio C, Benoist S, Allard MA, Navarro F, Pessaux P, Sa Cunha A, Brouquet A,
Lien Pubmed
Résumé
outcome of patients who develop resectable metachronous colorectal liver metastases (CLM) after adjuvant oxaliplatin-based chemotherapy for Stage III colorectal cancer (CRC) is not well defined and the value of preoperative chemotherapy is controversial.
Mots clés
hepatic recurrence, liver resection, metachronous, preoperative chemotherapy
Référence
J Surg Oncol. 2022 Apr 9;: